E.U. Medicines Agency Expected To Meet Dec. 21 To Consider Approval Of Pfizer-BioNTech COVID-19 Vaccine
AP: E.U. regulators move up Pfizer vaccine assessment to Dec. 21
“Facing strong pressure from Germany and other European Union nations, the bloc’s medicines agency on Tuesday moved up a meeting to assess the Pfizer-BioNTech coronavirus vaccine to Dec. 21, likely bringing vaccinations a step closer for millions of E.U. citizens. The agency said it made the decision after receiving additional data from the vaccine makers. The announcement came after Germany’s health minister and others had publicly demanded that the agency move quicker than its previously planned Dec. 29 meeting at which it was to discuss approving the vaccine…” (Grieshaber et al., 12/15).
Additional coverage of the expected meeting is available from DW and Financial Times.
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.